rss Posted November 28, 2013 Report Share Posted November 28, 2013 Related ArticlesEmerging therapies in rosacea. J Am Acad Dermatol. 2013 Dec;69(6 Suppl 1):S57-65 Authors: Layton A, Thiboutot D Abstract Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients. PMID: 24229638 [PubMed - in process] http://www.ncbi.nlm.nih.gov/pubmed/24229638?dopt=Abstract = URL to article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now